Carbapenem-resistant Acinetobacter baumannii (CRAB) causes colonization and infection
predominantly in hospitalized patients. Distinction between the two is a challenge. When …

The emergence of multidrug-resistant (MDR) Acinetobacter baumannii poses a therapeutic
problem. The aim of this study was to assess the risk factors for nosocomial MDR-A …

Abstract Background Carbapenem-resistant Acinetobacter baumannii (CRAB) has gained
global notoriety as a critically important nosocomial pathogen. It mostly affects debilitated …

Acinetobacter baumannii is an important nosocomial pathogen usually in the context of
serious underlying disease. Multidrug resistance in these organisms is frequent. The β …

We conducted a retrospective matched cohort study to examine the impact of isolation of
multi-drug-resistant (MDR) Acinetobacter baumannii on patient outcomes. Cases from whom …

Background: Multidrug-resistant (MDR) Acinetobacter baumannii are increasingly
encountered and frequently susceptible only to colistin with their MIC values close to …

Acinetobacter baumannii is an opportunistic bacterial pathogen primarily associated with
hospital-acquired infections. The recent increase in incidence, largely associated with …

This review critically appraises the published microbiologic and clinical data on the
treatment of patients with carbapenem‐resistant Acinetobacter baumannii infections …

Carbapenem-and multiply-resistant Acinetobacter baumannii (C-MRAB) are challenging
pathogens, often susceptible only to polymyxins and tigecycline. We reviewed clinical …

Background A. baumannii is an important nosocomial pathogen associated with high
mortality, morbidity and medical cost. Aim The aim of this study was to investigate risk factors …